help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, S.
Right arrow Articles by Christakos, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S.
Right arrow Articles by Christakos, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*1,25-DIHYDROXYCHOLECALCIFEROL
*BUTYRIC ACID
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL

Endocrinology, Vol 134, 1602-1610, Copyright © 1994 by Endocrine Society


ARTICLES

1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion

S Lee, SA Clark, RK Gill and S Christakos
Department of Biochemistry, University of Massachusetts Medical Center, Worcester 01605.

Previous studies have indicated that the pancreas has receptors specific for 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] and that 1,25- (OH)2D3 increases insulin secretion in vitamin D-deficient rats. In this study we report that in vitamin D-replete, but calcium-deficient, rats in which 1,25-(OH)2D3 levels are elevated, insulin secretion is not altered. In addition, in in vitro studies 1,25-(OH)2D3 at concentrations of 10(-10)-10(-7) M was consistently found to inhibit insulin secretion from islets of vitamin D-replete rats or from the rat insulinoma beta-cell line RIN 1046-38. The RIN cell line was found to contain both vitamin D receptors and calbindin-D28k (CaBP-D28k) protein and mRNA. In RIN cells, treatment with sodium butyrate (2 mM for 3 days) induces a more islet phenotype, as indicated by increased insulin content and secretion and increased insulin gene expression. 1,25- (OH)2D3 treatment (50-100 nM for 48 or 72 h) had no effect on the enhanced levels of insulin secreted in the presence of butyrate. However, 2 mM sodium butyrate induced CaBP-D28k protein (4-fold; control, 0.8 +/- 0.2; sodium butyrate, 3.5 +/- 0.1 microgram/mg protein) and mRNA (3-fold) in the RIN cell line, in accord with the induction by butyrate of insulin content and secretion and beta-cell differentiation, suggesting a possible role for CaBP-D28k in these processes. Although 1,25-(OH)2D3, unlike butyrate, did not enhance insulin secretion, both 1,25-(OH)2D3 (100 nM) and butyrate (2 mM) inhibited RIN cell growth (to 69% and 28% of the control, respectively), and butyrate and 1,25-(OH)2D3 in combination led to a further inhibition of cell growth (to 13% of the control). In response to 1,25-(OH)2D3 (10 nM for 72 h), vitamin D receptors were up-regulated 313% in RIN cells [control, 37 +/- 2; 1,25-(OH)2D3 treated, 115 +/- 5 fmol/mg protein]. In conclusion, 1) contrary to previous studies in the vitamin D-deficient rat, our findings indicate that 1,25-(OH)2D3 action does not necessarily result in enhanced insulin secretion; 2) inhibition of cell growth and up-regulation of vitamin D receptors by 1,25-(OH)2D3 suggest that parameters in addition to insulin secretion can be affected by 1,25-(OH)2D3 in the beta-cell; 3) the RIN beta-cell line provides a novel in vitro system for studying the effect of the vitamin D endocrine system on pancreatic islet physiology.


This article has been cited by other articles:


Home page
Diabetes CareHome page
J. P. Reis, D. von Muhlen, D. Kritz-Silverstein, D. L. Wingard, and E. Barrett-Connor
Vitamin D, Parathyroid Hormone Levels, and the Prevalence of Metabolic Syndrome in Community-Dwelling Older Adults
Diabetes Care, June 1, 2007; 30(6): 1549 - 1555.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. B Snijder, A. A. van der Heijden, R. M van Dam, C. D. Stehouwer, G. J Hiddink, G. Nijpels, R. J Heine, L. M Bouter, and J. M Dekker
Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoorn Study
Am. J. Clinical Nutrition, April 1, 2007; 85(4): 989 - 995.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
L. Schneider, C. El-Yazidi, A. Dace, M. Maraninchi, R. Planells, A. Margotat, and J. Torresani
Expression of the 1,25-(OH)2 vitamin D3 receptor gene during the differentiation of mouse Ob17 preadipocytes and cross talk with the thyroid hormone receptor signalling pathway
J. Mol. Endocrinol., February 1, 2005; 34(1): 221 - 235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. F Holick
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1678S - 1688S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. A. Bakken and C. D. Hunt
Dietary Boron Decreases Peak Pancreatic In Situ Insulin Release in Chicks and Plasma Insulin Concentrations in Rats Regardless of Vitamin D or Magnesium Status
J. Nutr., November 1, 2003; 133(11): 3577 - 3583.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Riachy, B. Vandewalle, J. Kerr Conte, E. Moerman, P. Sacchetti, B. Lukowiak, V. Gmyr, T. Bouckenooghe, M. Dubois, and F. Pattou
1,25-Dihydroxyvitamin D3 Protects RINm5F and Human Islet Cells against Cytokine-Induced Apoptosis: Implication of the Antiapoptotic Protein A20
Endocrinology, December 1, 2002; 143(12): 4809 - 4819.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Galbiati, L. Polastri, S. Gregori, M. Freschi, M. Casorati, U. Cavallaro, P. Fiorina, F. Bertuzzi, A. Zerbi, G. Pozza, et al.
Antitumorigenic and Antiinsulinogenic Effects of Calcitriol on Insulinoma Cells and Solid {beta}-Cell Tumors
Endocrinology, October 1, 2002; 143(10): 4018 - 4030.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
S. W.J. Janssen, J. G.J. Hoenderop, A. R.M.M. Hermus, F. C.G.J. Sweep, G. J.M. Martens, and R. J.M. Bindels
Expression of the Novel Epithelial Ca2+ Channel ECaC1 in Rat Pancreatic Islets
J. Histochem. Cytochem., June 1, 2002; 50(6): 789 - 798.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Sooy, T. Schermerhorn, M. Noda, M. Surana, W. B. Rhoten, M. Meyer, N. Fleischer, G. W. G. Sharp, and S. Christakos
Calbindin-D28k Controls [Ca2+]i and Insulin Release. EVIDENCE OBTAINED FROM CALBINDIN-D28k KNOCKOUT MICE AND beta CELL LINES
J. Biol. Chem., November 26, 1999; 274(48): 34343 - 34349.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Kajikawa, H. Ishida, S. Fujimoto, E. Mukai, M. Nishimura, J. Fujita, Y. Tsuura, Y. Okamoto, A. W. Norman, and Y. Seino
An Insulinotropic Effect of Vitamin D Analog with Increasing Intracellular Ca2+ Concentration in Pancreatic {beta}-Cells through Nongenomic Signal Transduction
Endocrinology, October 1, 1999; 140(10): 4706 - 4712.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M.-A. Huotari, J. Palgi, and T. Otonkoski
Growth Factor-Mediated Proliferation and Differentiation of Insulin-Producing INS-1 and RINm5F Cells: Identification of Betacellulin as a Novel {beta}-Cell Mitogen
Endocrinology, April 1, 1998; 139(4): 1494 - 1499.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Reddy, A. S. Pollock, S. A. Clark, K. Sooy, R. C. Vasavada, A. F. Stewart, T. Honeyman, and S. Christakos
Transfection and overexpression of the calcium binding protein calbindin-D28k results in a stimulatory effect on insulin synthesis in a rat beta  cell line (RIN 1046-38)
PNAS, March 4, 1997; 94(5): 1961 - 1966.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society